Publications
Find an abstract and a link to most of the publications produced by Nordic Bioscience
Find an abstract and a link to most of the publications produced by Nordic Bioscience
BACKGROUND: Abdominal aortic calcifications (AAC) predict cardiovascular mortality. A new scoring model for AAC, the Morphological Atherosclerotic Calcification Distribution (MACD) index may contribute with additional information to the commonly used Aortic Calcification Severity (AC24) score, when ...
December 20, 2011
Journal:
BMC Cardiovasc Disord
Author:
Barascuk N, Ganz M, Nielsen M, Register TC, Rasmussen LM, Karsdal MA, Christiansen C
Objective: We investigated whether breast cancer is predicted by a breast cancer risk mammographic texture resemblance (MTR) marker. Methods: A previously published case-control study included 495 women of which 245 were diagnosed with breast cancer. In baseline mammograms, 2-4 years prior to diagno...
August 1, 2011
Journal:
Cancer Epidemiol
Author:
Nielsen M, Karemore G, Loog M, Raundahl J, Karssemeijer N, Otten JD, Karsdal MA, Vanchon CM, Christiansen C
Summary: Early prognosis of osteoporosis risk is not only important to individual patients but is also a key factor when screening for osteoporosis drug trial populations. We present an osteoporosis fracture risk score based on vertebral heights. The score separated individuals who sustained fractur...
July 22, 2011
Journal:
Osteoporos Int.
Author:
Lillholm M, Ghosh A, Pettersen PC, de Bruijne M, Dam EB, Karsdal MA, Christiansen C, Genant HK, Nielsen M
Background: Aortic calcification is a major risk factor for death from cardiovascular disease. We investigated the relationship between mortality and the composite markers of number, size, morphology and distribution of calcified plaques in the lumbar aorta. Methods: 308 postmenopausal women aged 4...
November 10, 2010
Journal:
BMC Cardiovasc Disord
Author:
Nielsen M, Ganz M, Lauze F, Pettersen PC, Clarkson TB, Dam EB, Christiansen C, de Bruijne M, Karsdal MA
INTRODUCTION: At present, no disease-modifying osteoarthritis drugs (DMOADS) are approved by the FDA (US Food and Drug Administration); possibly partly due to inadequate trial design since efficacy demonstration requires disease progression in the placebo group. We investigated whether combinations ...
July 24, 2009
Journal:
Arthritis Res Ther
Author:
Dam EB, Loog M, Christiansen C, Byrjalsen I, Folkesson J, Nielsen M, Qazi AA, Pettersen PC, Garnero P, Karsdal MA
The aim of this study was to investigate whether transdermal low-dose estradiol treatment induces changes in mammographic density or heterogeneity compared with raloxifene, whether if these changes relate to changes in bone formation/resorption markers, and whether these findings indicate elevation ...
July 16, 2009
Journal:
Menopause
Author:
Nielsen M, Raundahl J, Pettersen PC, Loog M, Karemore G, Karsdal MA, Christiansen C
RATIONALE AND OBJECTIVES: Cartilage loss as determined by magnetic resonance imaging (MRI) or joint space narrowing as determined by x-ray is the result of cartilage erosion. However, metabolic processes within the cartilage that later result in cartilage loss may be a more sensitive assessment meth...
October 14, 2007
Journal:
Acad Radiol
Author:
Qazi AA, Dam EB, Nielsen M, Karsdal MA, Pettersen PC, Christiansen C
Search and find publications that we have published.
Please don't hesitate to contact us if you have any questions or other inquiries.
